Equillium, Inc. (EQ) Form 10-Q Quarterly Reports
Equillium, Inc. (EQ) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EQ
CIK: 1746466
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Crowe LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerThomas Shoemaker
Audit LocationCosta Mesa, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-05 | 2026-10-05 | 8-K | 0001193125-26-414364 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349235 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0001011438-26-000514 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349182 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000919574-26-004991 | View SEC Doc Filr Page |
| 144 | 2026-06-05 | — | 144 Filing | 0001974158-26-000073 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-05 | 4 Filing | 0001797818-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 Filing | 0001746808-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-06-04 | — | 144 Filing | 0001974158-26-000071 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 Filing | 0002012180-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 Filing | 0001198230-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 Filing | 0001559569-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 Filing | 0001236397-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | 4 Filing | 0001797818-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 Filing | 0001710696-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 Filing | 0001627886-26-000001 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-28 | 8-K | 0001193125-26-248246 | View SEC Doc Filr Page |
| 144 | 2026-05-27 | — | 144 Filing | 0001970051-26-000014 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001104659-26-062882 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001843384-26-000004 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001193125-26-221625 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | 8-K | 0001193125-26-221595 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-07 | — | SCHEDULE 13G Filing | 0001716774-26-000015 | View SEC Doc Filr Page |
| EFFECT | 2026-04-16 | — | EFFECT Filing | 9999999995-26-001220 | View SEC Doc Filr Page |
| ARS | 2026-04-15 | 2025-12-31 | ARS | 0001193125-26-156107 | View SEC Doc Filr Page |